Filter Results
:
(502)
Show Results For
- All HBS Web (502)
- Faculty Publications (365)
Show Results For
- All HBS Web (502)
- Faculty Publications (365)
- April 2003 (Revised October 2004)
- Case
Novartis: The Challenge of Success (B)
By: Sandra J. Sucher and Stacy McManus
When Dr. Daniel Vasella learned of the early Phase 1 trial results, he immediately decided what course of action Novartis would take. Students will be able to examine and assess the concrete steps, and the rationale behind them, that Novartis took in response to this...
View Details
Keywords:
Decision Making;
Moral Sensibility;
Innovation and Invention;
Distribution;
Product Development;
Production;
Problems and Challenges;
Research and Development;
Biotechnology Industry;
Biotechnology Industry
Sucher, Sandra J., and Stacy McManus. "Novartis: The Challenge of Success (B)." Harvard Business School Case 603-044, April 2003. (Revised October 2004.)
- April 2003 (Revised October 2004)
- Case
Novartis: The Challenge of Success (A)
By: Sandra J. Sucher and Stacy McManus
Preliminary results from Phase 1 clinical trials of a newly developed compound, STI571, showed that 31 out of 31 patients with chronic myelogenous leukemia (CML) had their blood counts return to normal. In the world of oncology, this was unheard of. This was the...
View Details
Keywords:
Decision Making;
Health Testing and Trials;
Innovation and Invention;
Markets;
Distribution;
Product Development;
Production;
Problems and Challenges;
Research;
Research and Development;
Complexity;
Biotechnology Industry;
Biotechnology Industry
Sucher, Sandra J., and Stacy McManus. "Novartis: The Challenge of Success (A)." Harvard Business School Case 603-043, April 2003. (Revised October 2004.)
- 2007
- Chapter
Fighting AIDS, Fighting Poverty: Customer Centric Marketing in the Generic Antiretroviral Business
By: Rohit Deshpandé and Zoe Chance
Keywords:
Health Disorders;
Poverty;
Product Marketing;
Customers;
Pharmaceutical Industry;
Pharmaceutical Industry
Deshpandé, Rohit, and Zoe Chance. "Fighting AIDS, Fighting Poverty: Customer Centric Marketing in the Generic Antiretroviral Business." In Business Solutions for the Global Poor: Creating Social and Economic Value, edited by V. Kasturi Rangan, John A. Quelch, Gustavo Herrero, and Brooke Barton. John Wiley & Sons, 2007.
- 2004
- Chapter
Genzyme's Gaucher Initiative: Global Risk and Responsibility
By: Christopher A. Bartlett and Andrew N. McLean
- Research Summary
Overview
By: Kyle R. Myers
Professor Myers studies the economics of what determines the rate and direction of innovation. He has examined the reallocation of scientists through the use of targeted research grants at the National Institutes of Health, and is working to further understand how...
View Details
Keywords:
Technology Networks;
Commercialization;
Science-Based Business;
Research and Development;
Knowledge Management;
Patents;
Innovation Strategy;
Technological Innovation;
Health Care and Treatment;
Entrepreneurship;
Health;
Innovation and Invention;
Science;
Technology;
Knowledge;
Intellectual Property;
Economics;
Microeconomics;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry
- September 1989 (Revised December 1989)
- Case
Beef Hormone Trade Dispute
By: Ray A. Goldberg
Keywords:
Trade;
Agribusiness;
Food;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry
Goldberg, Ray A. "Beef Hormone Trade Dispute." Harvard Business School Case 590-035, September 1989. (Revised December 1989.)
- September 2008
- Background Note
Background on the Technology of Molecular Diagnostics
By: Regina E. Herzlinger and Jason Sanders
To be used as background reading for the "EXACT Sciences Corp.: Commercializing a Diagnostic Test" and "Diagnostic Genomics" cases, HBS nos. 308-090 and 309-040.
View Details
Herzlinger, Regina E., and Jason Sanders. "Background on the Technology of Molecular Diagnostics." Harvard Business School Background Note 309-050, September 2008.
- 15 Oct 2008
- First Look
First Look: October 15, 2008
effectively within the newly merged entities. No PDF is available at this time. Reputation and Competition: Evidence from the Credit Rating Industry Authors:Bo Becker and Todd Milbourn Abstract Fair and accurate credit ratings arguably...
View Details
Keywords:
Martha Lagace
- 03 May 2011
- First Look
First Look: May 3
Download the paper: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1815370 Strategy as Innovation: Emergent Goal Formation in a Nascent Industry Authors:Tiona Zuzul and Amy C. Edmondson Abstract Building on research in strategy...
View Details
Keywords:
Sean Silverthorne
- July 2014 (Revised January 2017)
- Course Overview Note
Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Spring 2016 class Building Life Science Businesses.7
View Details
Keywords:
Healthcare Ventures;
Entrepreneurial Management;
Entrepreneurship;
Entrepreneurs;
Health Care and Treatment;
Health Testing and Trials;
Medical Specialties;
Health Industry;
Health Industry;
Health Industry;
Asia;
North America;
Europe
Hamermesh, Richard G. "Building Life Science Businesses Spring Term 2017: Course Outline and Syllabus." Harvard Business School Course Overview Note 815-003, July 2014. (Revised January 2017.)
- Web
CFO Letter - Annual Report 2019
Publishing, Harvard Business Review circulation continued to grow (counter to industry trends), and products launched by the Corporate Learning and Higher Education divisions were well-received. Leveraging space in new and newly renovated...
View Details
- 1997
- Chapter
Patent Scope and Emerging Industries: Biotechnology, Software, and Beyond
By: Josh Lerner and Robert P. Merges
Keywords:
Patents;
Applications and Software;
Genetics;
Information Technology Industry;
Information Technology Industry
Lerner, Josh, and Robert P. Merges. "Patent Scope and Emerging Industries: Biotechnology, Software, and Beyond." In Competing in the Age of Digital Convergence, edited by D. B. Yoffie, 301–324. Boston: Harvard Business School Press, 1997.
- September 2009 (Revised December 2009)
- Supplement
Genzyme Center (B)
By: Michael W. Toffel and Aldo Sesia
Genzyme Corporation is in the midst of planning its new corporate headquarters, which incorporates many innovative green building features. After learning that the building as planned would likely earn a LEED Silver rating, an intermediate score in the LEED green...
View Details
Keywords:
Environmental Sustainability;
Corporate Social Responsibility and Impact;
Standards;
Cost vs Benefits;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry
Toffel, Michael W., and Aldo Sesia. "Genzyme Center (B)." Harvard Business School Supplement 610-009, September 2009. (Revised December 2009.)
- March 2014
- Module Note
Implementing Environmentally Sustainable Operations
Keywords:
Sustainability;
Sustainability Management;
Sustainability Reporting;
Sustainable Supply Chains;
Sustainable Operations;
Environment;
Environmental And Social Sustainability;
Environmental Management;
Environmental Operations;
Environmental Performance;
Environmental Policy;
Environmental Protection;
Environmental Strategy;
Environmental Regulation;
Operations Management;
Operations Strategy;
Supply Chain Management;
Operations;
Supply Chain;
Business Processes;
Corporate Social Responsibility and Impact;
Performance Evaluation;
Performance Improvement;
Safety;
Social Enterprise;
Quality;
Production;
Working Conditions;
Animal-Based Agribusiness;
Buildings and Facilities;
Agriculture and Agribusiness Industry;
Agriculture and Agribusiness Industry;
Agriculture and Agribusiness Industry;
Agriculture and Agribusiness Industry;
Agriculture and Agribusiness Industry
Toffel, Michael W. "Implementing Environmentally Sustainable Operations." Harvard Business School Module Note 613-090, March 2014.
- September 2009 (Revised December 2009)
- Supplement
Genzyme Center (C)
By: Michael W. Toffel and Aldo Sesia
Genzyme Corporation is in the midst of planning its new corporate headquarters, which incorporates many innovative green building features. After learning that the building as planned would likely earn a LEED Silver rating, an intermediate score in the LEED green...
View Details
Keywords:
Environmental Sustainability;
Corporate Social Responsibility and Impact;
Standards;
Cost vs Benefits;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry
Toffel, Michael W., and Aldo Sesia. "Genzyme Center (C)." Harvard Business School Supplement 610-010, September 2009. (Revised December 2009.)
- Research Summary
Overview
I am interested in the individual experience of learning in organizational settings, particularly how employees learn to learn from the challenging work they do.
I am currently researching the role of reflection for raising awareness of learning opportunities that...
View Details
- Article
Internal Deadlines, Drug Approvals, and Safety Problems
By: Lauren Cohen, Umit Gurun and Danielle Li
Absent explicit quotas, incentives, reporting, or fiscal year-end motives, drug approvals around the world surge in December, at month-ends, and before respective major national holidays. Drugs approved before these informal deadlines are associated with significantly...
View Details
Keywords:
Health;
Economics;
Government and Politics;
Innovation and Invention;
Research;
Science;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry
Cohen, Lauren, Umit Gurun, and Danielle Li. "Internal Deadlines, Drug Approvals, and Safety Problems." American Economic Review: Insights 3, no. 1 (March 2021): 67–82.
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
modern industrial corporation encompasses a myriad of different software applications, which must work in concert to deliver functionality to end users. However, the increasingly complex and dynamic nature of competition in today’s...
View Details
Keywords:
Sean Silverthorne
- 15 Dec 2015
- News
The Year in Ideas 2015
most nimble creators will move from a mobile-first to a mobile-only approach. “The strongest brands will continue to do what they do best—superserve their audiences—but the native advertising model will meaningfully challenge the existing, archaic advertising model,...
View Details
- 1 Aug 2010
- Conference Presentation
Lords of the harvest: Symbolic signaling and regulatory approval of genetically modified organisms in the nascent U.S. agriculture-biotechnology sector
By: Shon R. Hiatt and Sangchan Park
Keywords:
Science;
Information Technology;
Governing Rules, Regulations, and Reforms;
Agribusiness;
Agriculture and Agribusiness Industry;
Agriculture and Agribusiness Industry;
United States
Hiatt, Shon R., and Sangchan Park. "Lords of the harvest: Symbolic signaling and regulatory approval of genetically modified organisms in the nascent U.S. agriculture-biotechnology sector." Paper presented at the Academy of Management Annual Meeting, Montreal, Canada, August 01, 2010.